Docs
🇬🇧
en
Mint Work
Sign in
Get Started
By
v1
An Intermediate-Size Patient Population Expanded Access Treatment Protocol Evaluating the Safety, Tolerability and Immune Effects of the Nasal Anti-CD3 Monoclonal Antibody Foralumab in Non-Active Secondary Progressive MS Patients Foralumab Nasal
Unknown
U
Unknown
NobleID
NI7P72W36R16S12
Type:
Journal Article
Claim Your Authorship
Cite
Sign in to see the full record
Creating an account is free.
Sign in
Create an account
For data access, contact
info@nobleid.org
.